Laxmi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 19-12-2024
- Paid Up Capital ₹ 4.44 M
as on 19-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.74 Cr
as on 19-12-2024
- Revenue 29.37%
(FY 2022)
- Profit 537.20%
(FY 2022)
- Ebitda 2362.02%
(FY 2022)
- Net Worth 936.76%
(FY 2022)
- Total Assets 130.60%
(FY 2022)
About Laxmi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 4.44 M.
The company currently has active open charges totaling ₹1.74 Cr.
Shrinivas Gangapuram and Varalaxmi Gangapuram serve as directors at the Company.
- CIN/LLPIN
U51101MH2012PTC231030
- Company No.
231030
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Laxmi Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrinivas Gangapuram  | Director | 15-May-2012 | Current |
| Varalaxmi Gangapuram | Director | 15-May-2012 | Current |
Financial Performance of Laxmi Pharmaceuticals.
Laxmi Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.37% increase. The company also saw a substantial improvement in profitability, with a 537.2% increase in profit. The company's net worth Soared by an impressive increase of 936.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Laxmi Pharmaceuticals?
In 2022, Laxmi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Nov 2022 | ₹1.59 M | Open |
Others Creation Date: 21 Jan 2022 | ₹0.50 M | Open |
Others Creation Date: 21 Jan 2022 | ₹0.50 M | Open |
How Many Employees Work at Laxmi Pharmaceuticals?
Unlock and access historical data on people associated with Laxmi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Laxmi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laxmi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
